Galapagos NV
GLPG
#4956
Rank
C$2.57 B
Marketcap
C$38.32
Share price
0.00%
Change (1 day)
-3.07%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): C$0.75 Billion

According to Galapagos NV's latest financial reports the company's current earnings are C$1.22 Billion. In 2025 the company made an earning of C$0.50 Billion, an increase over its 2024 earnings that were of -C$7.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.75 B48.14%
2025 C$0.50 B-6464.81%
2024 -C$7.99 Million-82.77%
2023 -C$46.36 Million-85.59%
2022 -C$0.33 Billion60.71%
2021 -C$0.21 Billion-60.08%
2020 -C$0.51 Billion-331.44%
2019 C$0.21 B-523.76%
2018 -C$51.14 Million-72.34%
2017 -C$0.19 Billion-329.59%
2016 C$80.53 M-144.3%
2015 -C$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.90 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.24 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$9.11 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.58 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$18.17 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.26 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.83 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-C$73.9 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.13 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel